查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2004287

α粒子发射装置市场：2026-2032年全球市场预测（依发射装置类型、设备类型、供应形式、纯度等级、侦测技术、应用和最终用户划分）

Alpha Emitters Market by Emitter Type, Equipment Type, Delivery Mode, Purity Grade, Detection Technique, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年， α发射体市场价值将达到 12.8 亿美元，到 2026 年将成长到 15.2 亿美元，到 2032 年将达到 48.1 亿美元，年复合成长率为 20.74%。

主要市场统计数据
基准年 2025 12.8亿美元
预计年份：2026年 15.2亿美元
预测年份 2032 48.1亿美元
复合年增长率 (%) 20.74%

对α发射体进行全面介绍，重点在于影响策略决策的科学进展、监管趋势和操作考量。

α放射性核种已从小众科学研究对象转变为临床、环境、工业和科研领域至关重要的工具。本文概述了当前的技术、监管和商业性格局，重点关注放射性核素生产创新与安全处理、检测和应用方面不断变化的需求之间的相互作用。此外，本文还着重介绍了α发射体的价值提案——它们独特的放射生物学特性使其能够实现高度局部的能量沉积，​​从而达到治疗目的；以及它们独特的信号，使其能够用于有针对性的环境和工业监测。

技术突破、更严格的法规以及具有韧性的供应链重组所引发的变革性环境变化，正在重新思考α放射性物质的部署。

受技术、政策和需求三者协同作用的影响，α发射体市场格局正在经历一场变革。同位素生产和发生器设计的突破性进展消除了以往的一些瓶颈，而检测器灵敏度和特异性的提升则拓展了其在临床治疗和环境监测等领域的应用前景。除了这些技术进步之外，临床研究人员对标靶α疗法的探索以及环境和工业从业者对更精确的检测能力的需求也日益增长。

到 2025 年，美国贸易措施的累积影响将推动采购体系的重组、对国内生产能力的投资以及一体化供应链中的风险缓解。

美国于2025年推出的新关税措施正在对α粒子排放生态系统产生累积影响，波及临床、工业和研究领域的相关人员采购计画、物流和成本结构。进口关税及相关贸易政策增加了依赖国际供应链采购同位素、发生器组件和专用设备的机构的交易复杂性。这些措施迫使采购团队重新评估总到岸成本，并将与交货延误和海关合规相关的风险溢价纳入成本。

透过详细的细分洞察，将应用需求、散热器类型、仪器模式、供应形式、纯度差异和检测技术连结起来，以实现策略协调。

细分市场洞察揭示了差异化的价值炼和部署路径，这对策略规划至关重要。就应用类别而言，环境监测活动涵盖空气监测、土壤采样和水质监测，在长期监测计画中，检测灵敏度和法规遵循往往是优先考虑的因素。工业测试依赖无损检测和厚度测量，透过可靠的检测器和标准化的放射性物质源，可以实现快速且可重复的测试。医疗疗法，包括镇痛和标靶α射线疗法，优先考虑严格的纯度和临床级生产。研发活动涵盖临床和临床前研究，需要灵活的放射源和高纯度放射性物质以确保研究条件的可重复性。这些特定应用的需求影响采购优先顺序、品质保证措施和技术规格。

实际的区域洞察，揭示了美洲、欧洲、中东和非洲以及亚太地区在采用、生产和监管方面的优先事项有何不同。

区域趋势凸显了美洲、欧洲、中东和非洲以及亚太地区在战略重点和实施路径上的差异。在美洲，先进的临床研究中心和工业检测机构的集中，催生了对高纯度放射性物质和精密检测系统的强劲需求。此外，法规环境日益重视供应稳定性和临床试验的完整性。这推动了对国内产能的投资，并促进了学术机构、医疗系统和私营供应商之间的合作伙伴关係，以确保治疗方案和监测活动的连续性。

主要企业洞察揭示了透过整合供应链、技术平台、知识产权和服务主导的竞争定位实现差异化。

α粒子发射材料领域的竞争格局取决于技术专长、法规遵循经验以及提供可靠供应链的能力。主要企业透过整合同位素生产和发生器製造、检验的检测技术以及全面的合规服务，提供一体化解决方案，脱颖而出。其他企业则专注于特定领域，例如高纯度生产流程、可扩展的发生器平台或适用于工业环境的可靠检测器。生产商、设备製造商和医疗机构之间的策略伙伴关係关係日益普遍，有助于加速临床试验进程、协调供应物流物流并建立风险共担机制。

为行业领导者提供切实可行的建议，以建立具有韧性的供应链，加快部署速度，并使创新与合规性和最终用户需求保持一致。

该行业的领导者应优先考虑一系列切实可行的措施，将机会转化为可持续的竞争优势。首先，投资建立具有韧性的供应链，将策略性库存管理与国内及近岸生产能力的伙伴关係结合，从而降低跨境中断和关税波动带来的风险。其次，优先考虑合规性和人才储备，建立经认证的培训项目、健全的品管体係以及符合不断变化的监管要求的透明文件记录流程。

透过高度透明、专家主导的调查方法，结合一手访谈、二手检验、跨领域整合和情境分析，得出可靠的见解。

本报告的调查方法结合了原始资料收集、专家访谈和严谨的二手资料分析，旨在建构关于α发射体现状的多维度观点。原始数据是透过与临床研究人员、环境监测从业人员、工业测试工程师、设备製造商和监管专家进行结构化对话收集的，以了解实际应用中的限制因素和驱动因素。这些观点与技术文献、监管指南和公开的技术摘要进行交叉比对，以检验推断出的趋势和技术能力。

一项旨在实现α发射体应用潜力的决定性整合，强调在能力、合规性、检验和伙伴关係方面的合作投资。

总之，α发射体占据着一个战略意义重大且技术复杂的领域，其科学潜力与监管和营运现实交织在一起。同位素生产、生成技术和检测器能力的进步正在拓展其在治疗、环境监测、工业测试以及研发等领域的应用范围，而监管和贸易趋势也在重塑采购和供应链策略。相关人员采取综合观点，将技术选择、合规准备和供应韧性结合，将更有利于将科学机会转化为可靠的专案成果。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：依发射容器型态分類的α粒子发射容器市场

  • 锕-225
  • 镅-241
  • 钋-210
  • 镭-223

第九章：α粒子发射装置市场：依设备分类

  • 检测器
    • 充气式检测器
    • 闪烁检测器
    • 固体检测器
  • 发电机
    • 盒式产生器
    • 列式产生器
  • 辐射源
    • 密封辐射源
    • 开放式辐射源

第十章：α粒子发射容器市场：以交付方式划分

  • 复合材料
  • 液体溶液
    • 缓衝溶液
    • 生理食盐水
  • 密封辐射源
    • 电镀散热器
    • 薄膜散热器

第十一章：以纯度等级分類的α粒子发射材料市场

  • 大部分
  • 无载体
  • 无载体

第十二章：依检测技术分類的α粒子发射装置市场

  • CdZnTe检测器
  • 高纯锗检测器
  • 电离室
  • NaI(Tl)闪烁器
  • 塑胶闪烁器
  • 比例计数器
  • 固体检测器

第十三章：α粒子发射装置市场：依应用领域划分

  • 环境监测
    • 大气监测
    • 土壤取样
    • 水质监测
  • 工业测试
    • 无损检测
    • 厚度测量
  • 药物治疗
    • 缓解疼痛
    • 标靶α射线疗法
  • 研究与开发
    • 临床试验
    • 临床前研究

第十四章：α粒子发射装置市场：依最终用户划分

  • 环保组织
  • 医院和诊所
  • 工业无损检测服务提供者
  • 研究机构

第十五章：α粒子发射容器市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章：α粒子发射装置市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章：α粒子发射材料市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国α粒子发射容器市场

第十九章：中国α粒子发射装置市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Actinium Pharmaceuticals Inc.
  • Alpha Tau Medical Ltd.
  • Bayer AG
  • Bracco Imaging SpA
  • Cardinal Health, Inc.
  • Fusion Pharmaceuticals Inc.
  • Jubilant Pharma Limited
  • Lantheus Holdings, Inc.
  • Nihon Medi-Physics Co., Ltd.
  • Niowave, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • Novartis AG
  • Orano Med
  • Phoenix LLC
  • RadioMedix Inc.
  • Telix Pharmaceuticals Limited
  • Theragenics Corporation
  • Viewpoint Molecular Targeting Inc.
Product Code: MRR-742BD517A934

The Alpha Emitters Market was valued at USD 1.28 billion in 2025 and is projected to grow to USD 1.52 billion in 2026, with a CAGR of 20.74%, reaching USD 4.81 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.28 billion
Estimated Year [2026] USD 1.52 billion
Forecast Year [2032] USD 4.81 billion
CAGR (%) 20.74%

Comprehensive introduction to alpha emitters highlighting scientific advances, regulatory dynamics, and operational considerations shaping strategic decisions

Alpha-emitting radionuclides have transitioned from niche scientific curiosities into pivotal tools across clinical, environmental, industrial, and research domains. This introduction frames the technical, regulatory, and commercial contours that define the present-day landscape, with attention to the interplay between innovation in radionuclide production and evolving requirements for safe handling, detection, and deployment. It clarifies the value proposition of alpha emitters: the unique radiobiological properties that enable highly localized energy deposition for therapy, and the signature signals that facilitate targeted environmental and industrial monitoring.

Over the last decade, improvements in isotope production pathways, generator technologies, and detector capabilities have reshaped practical access to and use of alpha emitters. Concurrently, regulatory authorities and institutional safety programs have tightened controls around sourcing, transport, and clinical application, creating both friction and opportunity. This introduction establishes the analytical lens used throughout the report: examining technological readiness, supply chain robustness, regulatory alignment, and end-user adoption dynamics. It emphasizes a pragmatic orientation-linking scientific capabilities to operational realities-so that decision-makers can prioritize investments that balance innovation with compliance and patient or environmental safety.

Finally, the introduction outlines how subsequent sections connect to one another. After situating the market forces and technological advances, the narrative proceeds to identify transformative shifts, assess policy-driven trade impacts, extract segmentation-driven insights, and present regional and competitive perspectives. The goal is to provide a cohesive foundation that supports strategic planning, partnership development, and risk mitigation for stakeholders across healthcare, environmental monitoring, industrial testing, and research sectors.

Transformative landscape shifts driven by technological breakthroughs, regulatory tightening, and resilient supply chain realignments reshaping alpha emitter adoption

The alpha emitters landscape is undergoing transformative shifts driven by converging forces in technology, policy, and demand. Breakthroughs in isotope production and generator design have reduced some historical bottlenecks, while advances in detector sensitivity and specificity have expanded feasible use cases in both clinical therapy and environmental surveillance. These technological improvements are complemented by increasing interest from clinical researchers exploring targeted alpha therapies, and from environmental and industrial practitioners seeking higher-fidelity detection capabilities.

Regulatory evolution is a parallel vector of change. Legislators and oversight bodies have responded to both safety concerns and therapeutic potential by tightening controls over transport, licensure, and clinical use. As a result, organizations are investing in compliance infrastructures, specialized handling protocols, and workforce training to meet more rigorous standards. This regulatory tightening, while introducing short-term complexity, is also raising overall confidence among institutional stakeholders and enabling more structured clinical trial programs and monitoring initiatives.

Supply chain dynamics constitute a third major shift. Greater attention to secure sourcing, onshoring, and diversification of production pathways is reshaping procurement strategies. Public and private actors alike are prioritizing resilient supply chains to reduce exposure to single-source vulnerabilities, particularly for high-value emitters used in therapy. Taken together, these technological, regulatory, and supply-chain shifts are transforming alpha emitters from specialized research inputs into strategically managed assets, prompting organizations to rethink partnerships, capital allocation, and long-term roadmaps.

Cumulative outcomes of United States trade measures in 2025 driving procurement reconfiguration, domestic capacity investment, and integrated supply chain risk mitigation

The introduction of new tariff measures in the United States in 2025 has had a cumulative influence on the alpha emitters ecosystem, affecting procurement planning, logistics, and cost structures for stakeholders across clinical, industrial, and research settings. Import duties and related trade policies have increased the transactional complexity for organizations that depend on international supply chains for isotopes, generator components, and specialized equipment. These measures have prompted procurement teams to reassess total landed cost considerations and to internalize risk premiums for delayed deliveries and customs-related compliance.

In response, some actors accelerated near-term investments in domestic production capabilities and strategic inventories to buffer against cross-border uncertainties. Such responses streamline continuity for critical clinical programs and industrial operations, but they also require capital and operational investments that alter deployment timelines and purchasing cycles. At the same time, tariff-driven cost pressures incentivized greater collaboration between suppliers and end users to negotiate supply agreements that incorporate shared risk mitigants, such as consignment models, scheduled replenishments, and joint investments in generator systems designed for longer in-field lifetime.

From an operational perspective, organizations recalibrated sourcing strategies, favoring suppliers with established logistics networks and transparent compliance practices. Many institutions intensified due diligence on vendor provenance, certificate-of-origin documentation, and customs handling capabilities. Overall, the 2025 tariff changes catalyzed a reorientation from transactional procurement toward integrated supply-chain partnerships, encouraging investments in domestic capabilities and more robust contractual safeguards to ensure continuity of clinical therapies, environmental monitoring programs, and industrial testing activities.

Deep segmentation insights connecting application needs, emitter types, equipment modalities, delivery formats, purity distinctions, and detection technologies for strategic alignment

Segmentation insights reveal differentiated value chains and adoption pathways that are essential for strategic planning. Considering application categories, environmental monitoring activities span air monitoring, soil sampling, and water monitoring and tend to prioritize detection sensitivity and regulatory compliance for long-term surveillance programs; industrial testing relies on non-destructive testing and thickness gauging where rugged detectors and standardized sources enable rapid, repeatable inspections; medical therapy encompasses pain palliation and targeted alpha therapy where stringent purity and clinical-grade production are paramount; research and development efforts cover clinical trials and preclinical research and demand both flexible sources and high-purity emitters for reproducible study conditions. These application-specific requirements shape procurement priorities, quality assurance practices, and technical specifications.

End-user perspectives further refine these distinctions. Environmental agencies emphasize regulatory alignment and community safety in monitoring deployments, hospitals and clinics focus on clinical workflows, dosimetry, and patient outcomes, industrial non-destructive testing providers prioritize operational throughput and equipment reliability, and research institutes require customizable sources and detection solutions to support experimental protocols. Each end user brings distinct expectations for supplier transparency, training, and after-sales support.

Emitter type selection is another pivotal segmentation axis. Actinium-225, Americium-241, Polonium-210, and Radium-223 each present unique production, handling, and application profiles that influence supply chain design and clinical or industrial adoption. Equipment type choices-detectors, generators, and sources-are differentiated by technical subtypes: detectors include gas-filled detectors, scintillation detectors, and solid state detectors; generators are available as cartridge generators or column generators; sources can be sealed or unsealed. These equipment distinctions affect operational workflows, maintenance regimes, and regulatory classification.

Delivery mode and formulation drive usability considerations. Composite materials, liquid solutions, and sealed sources represent different handling paradigms, and liquid solutions divided into buffered and saline formulations influence compatibility with clinical delivery systems. Sealed sources that are electroplated or manufactured as thin-film sources offer differing lifetimes and radiation profiles suited to industrial and calibration needs. Purity grade further stratifies the market into bulk, carrier-free, and no-carrier-added grades, each reflecting trade-offs between yield, chemical behavior, and suitability for therapeutic or analytical applications. Detection technique choices-spanning CdZnTe detectors, HPGe detectors, ionization chambers, NaI(Tl) scintillators, plastic scintillators, proportional counters, and solid state detectors-determine measurement precision, energy resolution, and operational complexity, directly informing capital expenditure and operational training requirements.

Synthesizing these segmentation dimensions highlights how technical characteristics, regulatory constraints, and end-user workflows coalesce to create distinct submarkets. Strategic decisions should therefore account for cross-segmentation interactions, such as how emitter type and purity grade inform generator selection and clinical applicability, or how detection technique and equipment form factor determine feasibility for field-based environmental monitoring versus centralized laboratory analysis.

Actionable regional insights illuminating how the Americas, Europe, Middle East & Africa, and Asia-Pacific exhibit distinct priorities for adoption, production, and regulation

Regional dynamics accentuate differing strategic priorities and execution pathways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a concentration of advanced clinical research centers and industrial testing providers creates robust demand for high-purity emitters and sophisticated detection systems, alongside a regulatory environment that increasingly emphasizes supply security and clinical trial integrity. This drives investment in domestic capabilities and collaborative partnerships between academic centers, healthcare systems, and commercial suppliers to ensure continuity of therapeutic programs and monitoring initiatives.

Across Europe, Middle East & Africa, regulatory harmonization and cross-border cooperation influence procurement approaches, with a focus on standardized safety protocols and interoperable instrumentation that can be deployed across diverse jurisdictions. Regional initiatives that prioritize public health surveillance and environmental protection create steady demand for monitoring solutions, while certain markets in the Middle East and Africa pursue capacity building in clinical and industrial radioisotope use through targeted investments and knowledge-transfer partnerships.

In the Asia-Pacific region, rapid growth in clinical research activity and industrial modernization is prompting accelerated adoption of targeted therapies and advanced detection technologies. Many countries in the region are expanding local production capabilities and investing in training programs to support safe handling and clinical deployment. Supply chain diversification remains a regional priority, with governments and private actors seeking to reduce dependency on single-source imports and to cultivate domestic expertise in isotope production and generator manufacturing.

Taken together, these regional insights underscore the importance of aligning commercial strategies with localized regulatory frameworks, clinical and industrial priorities, and capacity-building trajectories. Organizations should therefore tailor go-to-market and partnership approaches to reflect each region's specific mix of demand drivers, infrastructure maturity, and policy environment.

Key company insights revealing differentiation through integrated supply chains, technology platforms, intellectual property, and service-led competitive positioning

Competitive dynamics in the alpha emitters domain are defined by a combination of technical expertise, regulatory experience, and the ability to deliver reliable supply chains. Leading actors differentiate themselves through integrated offerings that pair isotope production or generator manufacturing with validated detection technologies and comprehensive compliance services. Others focus on specialization-whether in high-purity production routes, scalable generator platforms, or ruggedized detectors for industrial environments. Strategic partnerships between producers, instrument manufacturers, and healthcare institutions are increasingly common, enabling expedited clinical trials, coordinated supply logistics, and shared risk structures.

In addition to vertical integration and partnerships, companies are investing in intellectual property around generator design, source encapsulation techniques, and detector materials to secure competitive advantage. Service capabilities such as training, after-sales maintenance, and regulatory support are central to value propositions, particularly for end users with limited in-house nuclear expertise. Furthermore, firms that can demonstrate robust quality management systems and traceable chain-of-custody procedures tend to gain preference in procurement decisions, as buyers prioritize safety and compliance alongside technical performance.

Market entrants face high technical and regulatory barriers, so successful growth strategies typically combine focused R&D investments with targeted alliances and pilot programs that validate performance in real-world clinical or industrial settings. Ultimately, competitive success will depend on the ability to integrate technical excellence with operational reliability, transparent compliance practices, and strong customer support models.

Actionable recommendations for industry leaders to build resilient supply chains, accelerate adoption, and align innovation with compliance and end-user needs

Leaders in the field should pursue a set of actionable priorities to convert opportunity into durable advantage. First, invest in resilient supply architectures that blend strategic inventory management with partnerships for domestic and nearshore production capabilities, thereby reducing exposure to cross-border disruptions and tariff-related volatility. Second, prioritize compliance and workforce readiness by building accredited training programs, robust quality control systems, and transparent documentation practices that align with evolving regulatory expectations.

Third, accelerate clinical and industrial adoption by funding targeted pilot programs and real-world validation studies that demonstrate safety, efficacy, and operational benefits. Such evidence will expedite institutional buy-in and inform procurement specifications. Fourth, design modular product and service offerings that accommodate diverse end-user needs-from field-deployable detection kits for environmental agencies to clinical-grade generators and liquid formulations for therapeutic programs-so that customers can scale solutions as their requirements evolve.

Fifth, cultivate partnerships across the value chain, including alliances with research institutions, instrumentation manufacturers, and logistics specialists, to co-develop solutions that address cross-functional constraints. Finally, commit to continuous innovation in detector materials, generator efficiency, and source encapsulation technologies while maintaining transparent communication about supply provenance and safety practices. Implementing these priorities will enable organizations to reduce risk, accelerate adoption, and capture strategic opportunities as the ecosystem matures.

Transparent, expert-driven research methodology integrating primary interviews, secondary validation, cross-segmentation synthesis, and scenario analysis for robust insights

The research methodology underpinning this report combines primary intelligence gathering, expert interviews, and rigorous secondary analysis to construct a multi-dimensional view of the alpha emitters landscape. Primary inputs include structured conversations with clinical researchers, environmental monitoring practitioners, industrial test engineers, equipment manufacturers, and regulatory specialists to capture real-world constraints and adoption drivers. These perspectives are triangulated with technical literature, regulatory guidance, and publicly available technical briefs to validate inferred trends and technological capabilities.

Analytical approaches emphasize cross-segmentation synthesis, examining how application requirements, emitter types, equipment modalities, delivery formats, purity grades, and detection techniques interact to produce distinct operational needs. The methodology also accounts for policy and trade influences, using scenario analysis to explore how tariff changes, regulatory updates, and supply chain disruptions could affect procurement and deployment strategies. Quality assurance steps include cross-verification of technical claims, review by subject-matter experts, and systematic documentation of assumptions to ensure traceability and reproducibility of findings.

Transparency about limitations is central to the methodology. Where public data are limited, estimates are informed by expert consensus and corroborated through multiple independent sources. The approach favors actionable insights over speculative assertions and is designed to equip decision-makers with clear, defensible reasoning that can be applied to strategy development, procurement planning, and collaborative initiatives.

Conclusive synthesis emphasizing coordinated investments in capacity, compliance, validation, and partnerships to realize the promise of alpha emitter applications

In conclusion, alpha emitters occupy a strategically important and technically complex domain where scientific potential intersects with regulatory and operational realities. Advances in isotope production, generator technologies, and detector capabilities are expanding feasible applications in therapy, environmental monitoring, industrial testing, and research, while regulatory and trade developments are reshaping procurement and supply-chain strategies. Stakeholders that adopt an integrated view-aligning technical selection, compliance readiness, and supply resilience-will be better positioned to translate scientific opportunity into reliable programmatic outcomes.

The journey from innovation to routine application requires coordinated action across multiple dimensions: investing in capacity and training, establishing resilient sourcing and logistics, validating performance through pilots and trials, and building trust through transparent quality and compliance practices. By focusing on these priorities and leveraging partnerships across the value chain, organizations can mitigate risk, accelerate adoption, and ensure that alpha emitters deliver their intended clinical, environmental, and industrial benefits in a safe and sustainable manner.

This conclusion invites stakeholders to use the detailed insights in the full report to inform strategic choices, operational investments, and collaborative initiatives that will determine how this technology fulfills its promise in the years ahead.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Alpha Emitters Market, by Emitter Type

  • 8.1. Actinium-225
  • 8.2. Americium-241
  • 8.3. Polonium-210
  • 8.4. Radium-223

9. Alpha Emitters Market, by Equipment Type

  • 9.1. Detectors
    • 9.1.1. Gas-Filled Detectors
    • 9.1.2. Scintillation Detectors
    • 9.1.3. Solid State Detectors
  • 9.2. Generators
    • 9.2.1. Cartridge Generators
    • 9.2.2. Column Generators
  • 9.3. Sources
    • 9.3.1. Sealed Sources
    • 9.3.2. Unsealed Sources

10. Alpha Emitters Market, by Delivery Mode

  • 10.1. Composite Materials
  • 10.2. Liquid Solutions
    • 10.2.1. Buffered Solutions
    • 10.2.2. Saline Solutions
  • 10.3. Sealed Sources
    • 10.3.1. Electroplated Sources
    • 10.3.2. Thin-Film Sources

11. Alpha Emitters Market, by Purity Grade

  • 11.1. Bulk
  • 11.2. Carrier-Free
  • 11.3. No-Carrier-Added

12. Alpha Emitters Market, by Detection Technique

  • 12.1. CdZnTe Detectors
  • 12.2. HPGe Detectors
  • 12.3. Ionization Chambers
  • 12.4. NaI(Tl) Scintillators
  • 12.5. Plastic Scintillators
  • 12.6. Proportional Counters
  • 12.7. Solid State Detectors

13. Alpha Emitters Market, by Application

  • 13.1. Environmental Monitoring
    • 13.1.1. Air Monitoring
    • 13.1.2. Soil Sampling
    • 13.1.3. Water Monitoring
  • 13.2. Industrial Testing
    • 13.2.1. Non-Destructive Testing
    • 13.2.2. Thickness Gauging
  • 13.3. Medical Therapy
    • 13.3.1. Pain Palliation
    • 13.3.2. Targeted Alpha Therapy
  • 13.4. Research & Development
    • 13.4.1. Clinical Trials
    • 13.4.2. Preclinical Research

14. Alpha Emitters Market, by End User

  • 14.1. Environmental Agencies
  • 14.2. Hospitals & Clinics
  • 14.3. Industrial Non-Destructive Testing Providers
  • 14.4. Research Institutes

15. Alpha Emitters Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Alpha Emitters Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Alpha Emitters Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Alpha Emitters Market

19. China Alpha Emitters Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Actinium Pharmaceuticals Inc.
  • 20.6. Alpha Tau Medical Ltd.
  • 20.7. Bayer AG
  • 20.8. Bracco Imaging S.p.A.
  • 20.9. Cardinal Health, Inc.
  • 20.10. Fusion Pharmaceuticals Inc.
  • 20.11. Jubilant Pharma Limited
  • 20.12. Lantheus Holdings, Inc.
  • 20.13. Nihon Medi-Physics Co., Ltd.
  • 20.14. Niowave, Inc.
  • 20.15. NorthStar Medical Radioisotopes, LLC
  • 20.16. Novartis AG
  • 20.17. Orano Med
  • 20.18. Phoenix LLC
  • 20.19. RadioMedix Inc.
  • 20.20. Telix Pharmaceuticals Limited
  • 20.21. Theragenics Corporation
  • 20.22. Viewpoint Molecular Targeting Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ALPHA EMITTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ALPHA EMITTERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ALPHA EMITTERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ALPHA EMITTERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ALPHA EMITTERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES ALPHA EMITTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA ALPHA EMITTERS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ALPHA EMITTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ALPHA EMITTERS MARKET SIZE, BY POLONIUM-210, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ALPHA EMITTERS MARKET SIZE, BY POLONIUM-210, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ALPHA EMITTERS MARKET SIZE, BY POLONIUM-210, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-223, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-223, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-223, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GAS-FILLED DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GAS-FILLED DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GAS-FILLED DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SCINTILLATION DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SCINTILLATION DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SCINTILLATION DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARTRIDGE GENERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARTRIDGE GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARTRIDGE GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COLUMN GENERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COLUMN GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COLUMN GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ALPHA EMITTERS MARKET SIZE, BY UNSEALED SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ALPHA EMITTERS MARKET SIZE, BY UNSEALED SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ALPHA EMITTERS MARKET SIZE, BY UNSEALED SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COMPOSITE MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COMPOSITE MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BUFFERED SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BUFFERED SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BUFFERED SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SALINE SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SALINE SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SALINE SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ELECTROPLATED SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ELECTROPLATED SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ELECTROPLATED SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THIN-FILM SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THIN-FILM SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THIN-FILM SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BULK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BULK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BULK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARRIER-FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARRIER-FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARRIER-FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NO-CARRIER-ADDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NO-CARRIER-ADDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NO-CARRIER-ADDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CDZNTE DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CDZNTE DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CDZNTE DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HPGE DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HPGE DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HPGE DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ALPHA EMITTERS MARKET SIZE, BY IONIZATION CHAMBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ALPHA EMITTERS MARKET SIZE, BY IONIZATION CHAMBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ALPHA EMITTERS MARKET SIZE, BY IONIZATION CHAMBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NAI(TL) SCINTILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NAI(TL) SCINTILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NAI(TL) SCINTILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLASTIC SCINTILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLASTIC SCINTILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLASTIC SCINTILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROPORTIONAL COUNTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROPORTIONAL COUNTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROPORTIONAL COUNTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AIR MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AIR MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AIR MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOIL SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOIL SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOIL SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ALPHA EMITTERS MARKET SIZE, BY WATER MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ALPHA EMITTERS MARKET SIZE, BY WATER MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ALPHA EMITTERS MARKET SIZE, BY WATER MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THICKNESS GAUGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THICKNESS GAUGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THICKNESS GAUGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PAIN PALLIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PAIN PALLIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PAIN PALLIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ALPHA EMITTERS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ALPHA EMITTERS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ALPHA EMITTERS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL NON-DESTRUCTIVE TESTING PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL NON-DESTRUCTIVE TESTING PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL NON-DESTRUCTIVE TESTING PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL ALPHA EMITTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS ALPHA EMITTERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 276. AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. AFRICA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 278. AFRICA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 279. AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 280. AFRICA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 281. AFRICA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. ASEAN ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. ASEAN ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 304. ASEAN ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 305. ASEAN ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 306. ASEAN ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 307. ASEAN ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 308. ASEAN ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 309. ASEAN ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 310. ASEAN ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 311. ASEAN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 312. ASEAN ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 313. ASEAN ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 314. ASEAN ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 315. ASEAN ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 316. ASEAN ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. GCC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 318. GCC ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. GCC ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. GCC ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 321. GCC ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 322. GCC ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 323. GCC ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 324. GCC ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 325. GCC ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 326. GCC ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 327. GCC ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 328. GCC ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. GCC ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 330. GCC ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 331. GCC ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 332. GCC ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 333. GCC ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 334. EUROPEAN UNION ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 335. EUROPEAN UNION ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 336. EUROPEAN UNION ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. EUROPEAN UNION ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 338. EUROPEAN UNION ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 339. EUROPEAN UNION ALPHA EMITTERS MARKET SIZE,